Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ETR/AFX stock hub

ETR/AFX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/AFXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.3B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/AFX

In the news

Latest news · ETR/AFX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.6

P25 12.3P50 15.7P75 20.2

Trailing P/E18.4

P25 16.4P50 20.9P75 30.4

ROE5.8

P25 -6.7P50 8.5P75 17.2

ROIC5.4

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/AFX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

EUR

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	5,784
Employees Change	54%
Employees Change Percent	0.94
Enterprise value	EUR 2.8B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	DE0005313704
Last refreshed	2026-05-10
Market cap	EUR 2.3B
Price	EUR 25.72
Price currency	EUR
Rev Per Employee	381,076.24x
Sector	Healthcare
Sic	3845
Symbol	etr/AFX
Website	https://www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.36%
EV Earnings	22.97x
EV/EBIT	14.16x
EV/EBITDA	10.08x
EV/Sales	1.26x
Forward P/E	15.62x
P/B ratio	1.06x
P/E ratio	18.37x
P/S ratio	1.02x
PE Ratio10 Y	43.01x
PE Ratio3 Y	31.61x
PE Ratio5 Y	40.36x
PEG ratio	1.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.85%
EBITDA Margin	11.28%
Gross margin	52.19%
Gross Profit	EUR 1.2B
Gross Profit Growth	5.7%
Gross Profit Growth Q	-9.88%
Gross Profit Growth3 Y	-0.06%
Gross Profit Growth5 Y	9.03%
Net Income	EUR 120.6M
Net Income Growth	-23.19%
Net Income Growth Years	0%
Net Income Growth3 Y	-26.76%
Net Income Growth5 Y	-1.47%
Pretax Margin	7.64%
Profit Margin	5.47%
Profit Per Employee	EUR 20,852
Profitable Years	21
Roa5y	7.01
ROE	5.82
Roe5y	12.07
ROIC	5.35
Roic5y	10.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.49%
Cagr15y	4.72%
Cagr1y	-55.07%
Cagr20y	4.51%
Cagr3y	-39.44%
Cagr5y	-28.41%
Div CAGR10	3.77%
Div CAGR3	-20.63%
Div CAGR5	1.92%
EPS Growth	-21.19
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-25.89
EPS Growth5 Y	-0.8
Revenue Growth	5.89x
Revenue Growth Q	-4.79x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	3.94x
Revenue Growth5 Y	10.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	EUR 27.3M
Debt	EUR 534.9M
Debt EBITDA	EUR 1.95
Debt Equity	EUR 0.25
Equity	EUR 2.1B
Interest Coverage	7.59
Net Cash	EUR -507.7M
Net Cash By Market Cap	EUR -22.55
Net Debt EBITDA	EUR 2.04
Net Debt Equity	EUR 0.24
Tangible Book Value	EUR 866.8M
Tangible Book Value Per Share	EUR 9.9
WACC	10

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.54%
Dividend Growth	-8.33%
Dividend Growth Years	0%
Dividend per share	EUR 0.55
Dividend Years	21
Dividend Yield	2.14%
Ex Div Date	2026-03-27
Last Dividend	EUR 0.55
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-4.77%
1Y total return	-55.05%
200-day SMA	37.06
3Y total return	-77.8%
50-day SMA	25.54
50-day SMA vs 200-day SMA	50under200
5Y total return	-81.2%
All Time High	202
All Time High Change	-87.27%
All Time High Date	2021-09-17
All Time Low	4.01
All Time Low Change	541.4%
All Time Low Date	2001-08-17
ATR	0.91
Beta	1.33
Beta1y	1.14
Beta2y	1.6
Ch YTD	-35.7
High	26.02
High52	66.6
High52 Date	2025-05-14
High52ch	-61.38%
Low	25.46
Low52	22.62
Low52 Date	2026-03-23
Low52ch	13.71%
Ma50ch	0.71%
Price vs 200-day SMA	-30.6%
RSI	45.57
RSI Monthly	28.22
RSI Weekly	32.28
Sharpe ratio	-1.95x
Sortino ratio	-2.29
Total Return	4.68%
Tr YTD	-34.25
Tr15y	99.74%
Tr1m	3.38%
Tr1w	-5.02%
Tr3m	-4.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 195M
Operating Income Growth	20.81
Operating Income Growth3 Y	-20.29
Operating Income Growth5 Y	0.16
Operating margin	8.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,676,702%
Shares Institutions	15.28%
Shares Out	87,536,079
Shares Qo Q	-6.35%
Shares Yo Y	-2.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	188,934.45x
Bv Per Share	24.18
Ch10y	-13.2
Ch15y	67.23
Ch1m	3.38
Ch1w	-5.02
Ch1y	-56.03
Ch20y	30.29
Ch3m	-6.54
Ch3y	-78.69
Ch5y	-82.27
Ch6m	-39.43
Change	0.16%
Change From Open	0.78
Close	25.68
Days Gap	-0.62
Depreciation Amortization	53,643,500
Dollar Volume	4,354,370.3
Earnings Date	2026-05-12
EBIT	EUR 195M
EBITDA	EUR 248.6M
EPS	EUR 1.4
F Score	1
Fiscal Year End	September
Founded	1,846
Graham Number	27.45054
Graham Upside	6.73
Income Tax	EUR 46.5M
Is Primary Listing	1
Last Earnings Date	2026-02-12
Last Report Date	2025-12-31
Lynch Fair Value	EUR 6.89
Lynch Upside	-73.21
Ma150	34.58
Ma150ch	-25.62%
Ma20	26.7
Ma20ch	-3.67%
Next Earnings Date	2026-05-12
Open	25.52
Payment Date	2026-03-31
Position In Range	46.43
Price Date	2026-05-08
Price EBITDA	EUR 9.05
Ptbv Ratio	2.6
Relative Volume	0.9x
Revenue	2,204,145,000x
Tax By Revenue	2.11x
Tax Rate	27.66%
Tr20y	141.84%
Tr6m	-38.06%
Volume	169,299

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/AFX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.1%

$0.55 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.9%

0 consecutive years of growth

Total shareholder yield

+4.7%

Next ex-dividend date: 2026-03-27

Performance

ETR/AFX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/AFX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.5%

Negative means the company is buying back shares.

Technical

ETR/AFX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.6

Neutral momentum band

Price vs 200-day MA

-30.6%

50/200-day relationship not available

Beta (5Y)

1.33

More volatile than the market

Sharpe ratio

-1.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/AFX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/AFX stock rating?

etr/AFX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/AFX analysis?

The full report lives at /stocks/etr/AFX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/AFX?

The latest report frames etr/AFX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/AFX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.